HANOI, VIETNAM - Media OutReach Neswire - 14 April 2025 - Together with world-renowned scientists including Prof. Joel F.

HANOI, VIETNAM / ACCESS Newswire / April 14, 2025 / Together with world-renowned scientists including Prof. Joel F. Habener, ...

The escalating global prevalence of obesity and type 2 diabetes mellitus (T2DM) underscores the urgent need for innovative ...

GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a ...

How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, ...

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk ...

Rare sugars like D-allulose, D-tagatose, and D-sorbose significantly boosted GLP-1 secretion and suppressed food intake in ...

People taking an oral formulation of the glucagon-like peptide-1 (GLP-1) agonist semaglutide were 14% less likely than those taking a placebo to experience cardiovascular death, heart attack or stroke ...

The addition of a candidate targeting glucagon, as well as GLP-1 and GIP ... We believe that Novo Nordisk’s expertise will play a key role in accelerating the global development of UBT251.” This ...

The Grammy award winner has landed her first lead role as she is set to play Sister Rosetta Tharpe, an American gospel singer known as the "Godmother of rock and roll," in Amazon MGM Studios' Rosetta.

The addition of a candidate targeting glucagon, as well as GLP-1 and GIP ... We believe that Novo Nordisk's expertise will play a key role in accelerating the global development of UBT251." This ...